[Troponin component of the cardiotropic effect of levosimendan on the isolated myocardium from patients with chronic coronary insufficiency].
Afanas'ev
S A
SA
Timofeev
V Iu
VIu
Karpov
R S
RS
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D002316:Cardiotonic Agents / Q000494:pharmacology*; D002908:Chronic Disease; D004837:Epinephrine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology*; D066298:In Vitro Techniques; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D017202:Myocardial Ischemia / Q000503:physiopathology*; D011724:Pyridazines / Q000494:pharmacology*; D000077464:Simendan; D013268:Stimulation, Chemical
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan; D004837:Epinephrine
Troponinovyĭ komponent kardiotonicheskogo deĭstviia levosimendana na izolirovannyĭ miokard bol'nykh s khronicheskoĭ koronarnoĭ nedostatochnost'iu.